- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence-based management of optic neuritis
Authors
Keywords
-
Journal
CURRENT OPINION IN OPHTHALMOLOGY
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-17
DOI
10.1097/icu.0000000000001007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks
- (2023) John J. Chen et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art Review
- (2022) Bart K. Chwalisz et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis
- (2022) George Saitakis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Emerging drugs for the treatment of adult MOG-IgG-associated diseases
- (2021) Edgar Carnero Contentti et al. EXPERT OPINION ON EMERGING DRUGS
- Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) – preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial
- (2020) Christian Albert et al. BMC Neurology
- Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
- (2020) Anthony Traboulsee et al. LANCET NEUROLOGY
- Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
- (2020) Chao Zhang et al. LANCET NEUROLOGY
- Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
- (2020) Masayuki Tahara et al. LANCET NEUROLOGY
- Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
- (2020) John J. Chen et al. NEUROLOGY
- Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis
- (2020) Sakdipat Songwisit et al. Scientific Reports
- The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
- (2019) CL de Mol et al. Multiple Sclerosis Journal
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- (2019) Sean J. Pittock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and tolerability of mitoxantrone for neuromyelitis optica spectrum disorder: A systematic review
- (2019) Clare Angeli G. Enriquez et al. JOURNAL OF NEUROIMMUNOLOGY
- Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
- (2019) Alvaro Cobo-Calvo et al. Journal of Neuroinflammation
- Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
- (2019) Hadas Stiebel-Kalish et al. Neurology-Neuroimmunology & Neuroinflammation
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- (2019) Bruce A C Cree et al. LANCET
- Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis
- (2019) John J. Chen et al. CURRENT OPINION IN NEUROLOGY
- Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
- (2019) Takashi Yamamura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
- (2018) Yael Hacohen et al. JAMA Neurology
- Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids
- (2018) Sarah A. Morrow et al. JAMA Neurology
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome
- (2018) John J. Chen et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
- (2017) Sudarshini Ramanathan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
- (2017) Diego Cadavid et al. LANCET NEUROLOGY
- Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
- (2017) Bo Chen et al. Scientific Reports
- Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study
- (2016) Yan Xu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhian Raftopoulos et al. LANCET NEUROLOGY
- Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
- (2016) Alexis Montcuquet et al. Multiple Sclerosis Journal
- Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
- (2016) Alexis Montcuquet et al. Multiple Sclerosis Journal
- Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
- (2015) Ingo Kleiter et al. ANNALS OF NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica
- (2015) Su-Hyun Kim et al. JAMA Neurology
- Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Aaron E Miller et al. LANCET NEUROLOGY
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- Efficacy of Intravenous Cyclophosphamide Therapy for Neuromyelitis Optica Spectrum Disorder
- (2013) Hiroaki Yaguchi et al. INTERNAL MEDICINE
- Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
- (2013) J. Kitley et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Optic neuritis
- (2013) Ahmed T Toosy et al. LANCET NEUROLOGY
- Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
- (2012) Ingo Kleiter ARCHIVES OF NEUROLOGY
- Treatment of Optic Neuritis by Plasma Exchange (Add-On) in Neuromyelitis Optica
- (2012) Harold Merle et al. ARCHIVES OF OPHTHALMOLOGY
- Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
- (2012) Su-Hyun Kim et al. Multiple Sclerosis Journal
- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial
- (2011) Giancarlo Comi et al. LANCET NEUROLOGY
- Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
- (2011) Ju-Hong Min et al. Multiple Sclerosis Journal
- Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
- (2011) C. Costanzi et al. NEUROLOGY
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
- (2009) Anu Jacob et al. ARCHIVES OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started